UK chief scientific adviser has £600,000 shareholding in firm contracted to develop vaccines
Revealed: Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines www.telegraph.co.uk | September 23, 2020 The UK’s chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, … Continue reading →